Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 3Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 4Other neoplasm 1

Conditions

Keratosis, Actinic 4Neoplasms 2Keratosis 2Stomach Neoplasms 1Precancerous Conditions 1Lymphoma 1Leukemia, Myeloid, Acute 1Carcinoma 1Breast Neoplasms 1Bone-Metastatic, Castration-Resistant Prostate Cancer 1

Interventions

3-ingenyl angelate 33Imiquimod 18Aminolevulinic Acid 16Gels 10Diclofenac 10Photochemotherapy 7methyl 5-aminolevulinate 6Fluorouracil 6Solutions 5LEO 43204 5BF-200 ALA 5tirbanibulin 4Ointments 4Cryotherapy 3SR-T100 2potassium dobesilate 1green tea extract polyphenone E 1beta-solamarine 1afamelanotide 1Therapies, Investigational 1Therapeutics 1Petrolatum 1Excipients 1Drugs, Generic 1Cryosurgery 1Control Groups 1AVX001 15-fluorouracil, salicylic acid drug combination 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Keratosis, Actinic × tirbanibulin × Clear all
NCT06135415 2026-03-25

TirbAKare

Almirall, S.A.

Phase 3 Completed
280 enrolled
DermatologicOther neoplasm

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting
447 enrolled
Dermatologic

Keratosis, Actinic

NCT05260073 2024-09-20

PROAK

Almirall, S.A.

Completed
300 enrolled 9 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡